Professors Robert Damoiseaux and Vaithilingaraja Arumugaswami led a collaboration among scientists from the U.S. and Germany.
Leading the research for UCLA are Istvan Mody, Varghese John and S. Thomas Carmichael.
Research brief: An approach pioneered at UCLA predicts which methicillin-resistant Staphylococcus aureus infections are likely to be cured with antibiotic therapy.
Research brief: The study is aimed at helping doctors ensure their patients adhere to medication regimens.
Despite a government initiative to improve access to end-of-life painkillers, dispensing levels in the wealthiest areas still far outpace the rest of the country.
About 480 health care workers are expected to be vaccinated today.
Research brief: The new finding highlights the need for alternative therapies for patients who are resistant to chemotherapy and radiation.
Those who underwent emergency surgeries on their surgeon’s birthday were 23% more likely to die within a month, a UCLA-led study shows.
Kristen Choi says doctors and nurses should be prepared to discuss side effects with patients and reassure them about the vaccine’s safety.
Clarivate released its annual list of the most highly cited researchers, which includes dozens of UCLA researchers across various disciplines.
UCLA Magazine speaks with doctors on the front lines who are helping the world combat the deadly virus.
UCLA research paves the way for new diagnostic and therapeutic approaches.
The findings are published in the New England Journal of Medicine.
The team will investigate the mechanisms of treatment resistance, laying the groundwork for new and improved combination therapies.
A UCLA-led team found that of 106 subjects who had a particular strain of the infection, all were cured with a single dose of ciprofloxacin.
A single protein may determine the size of scars, scientists say. Larger scars heighten the risk of future death from heart failure.
Two members of the UCLA Broad Stem Cell Research Center have received a grant for work that could be helpful in developing a vaccine.
Research brief: The advance could accelerate large-scale testing and diagnosis of people with genetic and metabolic disorders.
Researchers will focus on an immunotherapy known as CAR T, which uses genetically modified stem cells to target and destroy the virus.
A unique approach developed at UCLA suggests a possible path toward treatments for other types of severe infection.
Having witnessed the struggles of her own family and others, Melissa Rios learned early on how education, poverty and health are linked.
Research brief: Findings from a UCLA study indicate some men may not require the intensive treatment they have traditionally received.
The award from the National Cancer Institute will fund a series of collaborative research projects over five years at UCLA.
The immunotherapy drug combination is currently being reviewed for approval under a new FDA pilot program.
By repurposing drugs originally intended for other uses, scientists are pushing forward the fight against cancer.